Rapid early progression (REP) of glioblastoma is an independent negative prognostic factor: Results from a systematic review and meta-analysis.

Neurooncol Adv · 2022 · PMC9234755 · PMID 35769410

Europe PMC DOI

hedged sentence

0.1000

closest p · 2.0× alpha

0.1000

boldest claim

The sentences

did not reach statistical significanceP = .10so close (0.05 < p ≤ 0.1)

Studies with less than the median rate of GTR had a higher incidence rate of REP although differences did not reach statistical significance (OR 2.07, 95% CI 1.75–2.45, Chi-squared = 2.67, P = .10; Figure 4A ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.